Inotersen Sodium and Insulin glargine and lixisenatide
Determining the interaction of Inotersen Sodium and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Sodium-Insulin glargine and lixisenatide Subcutaneous
- Inotersen Sodium-Insulin glargine, recombinant Subcutaneous
- Inotersen Sodium-Insulin glulisine
- Inotersen Sodium-Insulin Glulisine (Cartridges and Pens)
- Inotersen Sodium-Insulin Glulisine (Vials)
- Inotersen Sodium-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Inotersen Subcutaneous
- Insulin glargine and lixisenatide-Inotuzumab ozogamicin
- Insulin glargine and lixisenatide-Inotuzumab ozogamicin Intravenous
- Insulin glargine and lixisenatide-Inova
- Insulin glargine and lixisenatide-Inova 4/1 topical
- Insulin glargine and lixisenatide-Inova 8/2 topical